National Institutes of Health (NIH)

332 articles about National Institutes of Health (NIH)

• ATCC Announces Award from the National Cancer Institute to Provide Biospecimen Processing Services and Assays for Cancer Research

  3/19/2024

  ATCC will continue to support the National Cancer Institute's (NCI) mission to prevent cancer and the Division of Cancer Epidemiology and Genetics (DCEG) Biospecimen Activity and Assay Support (BAAS) program.

• Feinstein Institutes Gets $3.1M NIH Grant to Further Understanding and Treatment of Psychiatric Illnesses Like ADHD, Schizophrenia, Autism

  2/20/2024

  Brain-based impairments in memory, reasoning and planning – collectively known as cognitive deficits – are present in several major neuropsychiatric disorders, most notably schizophrenia, affective disorders, autism spectrum disorders and attention-deficit/hyperactivity disorder.

• Maxim Biomedical, Inc. Secures Second NIH RADx Tech High Performance Award for Continued Development of At-Home FiarFly™ Reader and COVID-19 & Flu A/B Rapid Test

  2/1/2024

  MaximBio is pleased to announce that it has been granted a second follow-on award from the National Institutes of Health Rapid Acceleration of Diagnostics Tech program for the continued development of its revolutionary FiarFly™ reader and COVID-19 & Flu A/B multiplex test.

• Diakonos Oncology Names Ian H. Bellayr, Ph.D. Chief Regulatory Officer

  11/20/2023

  Diakonos Oncology Corporation announced that Ian H. Bellayr, Ph.D., a regulatory expert with the U.S. Food and Drug Administration and National Institutes of Health, has joined the company as its Chief Regulatory Officer.

• ATCC Announces Award from National Institute of Allergy and Infectious Diseases to Support Its Preclinical Services for Biopharmaceutical Product Development

  11/7/2023

  ATCC , the world’s premier biological materials management and standards organization, today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract 75N93023D00009 by the National Institute of Allergy and Infectious Diseases ( NIAID ), part of the National Institutes of Health (NIH).

• Integral Molecular Secures Nearly $900K in NIH Funding to Discover Antibodies Against Difficult and Conserved Protein Targets

  10/5/2023

  Integral Molecular, a leading biotech company specializing in antibody discovery against challenging protein targets, announces that it has been awarded NIH funding totaling $896,000.

• Actinium Announces NIH Grant Extension to Advance Clinical Development of Next-Generation CD45 Targeted Conditioning Agent Iomab-ACT with Memorial Sloan Kettering's CAR-T Cell Therapy

  10/4/2023

  Actinium Pharmaceuticals, Inc. announced the National Institutes of Health (NIH) awarded Actinium a Small Business Technology Transfer grant extension to support its clinical collaboration with Memorial Sloan Kettering Cancer Center (MSK) to study Iomab-ACT.

• Golden Helix Receives New NIH SBIR Grant

  9/26/2023

  Golden Helix, Inc. announced that it was awarded the NIH SBIR Grant 1R43HG013456-01 "Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options.".

• National Institutes of Health To Locate Signature Research Program on the Phoenix Bioscience Core

  9/15/2023

  Wexford Science & Technology, LLC announced that the National Institutes of Health has signed a lease at 850 PBC and will use the space to accommodate the Phoenix Epidemiology & Clinical Research Branch of the NIH's National Institute of Diabetes and Digestive and Kidney Diseases.

• Daxor Corporation Awarded $305K Grant from the National Institutes of Health to Develop Blood Volume Guidance Software in Sepsis Patients

  9/11/2023

  Daxor Corporation announced that the National Institutes of Health National Institute of General Medical Sciences has awarded the Company a $305K Phase I Small Business Innovative Research grant to support the development of the Sepsis FLO, a clinical decision support tool designed to precisely guide blood volume management and treatment in sepsis patients.

• NDRI Receives $3.7 Million Grant from NIH to Continue the Development of NDRI’s Human Tissue and Organs for Research Resource (HTORR) Program

  9/6/2023

  The National Disease Research Interchange has been awarded $3.7M by the National Institutes of Health to support continued national leadership with the recovery and distribution of human organs and tissues for medical research.

• Amprion Announces Collaboration with NIH Researchers on Dementia Hallmark Study

  8/23/2023

  Amprion has been contracted by the National Institutes of Health Intramural Research Program's Center for Alzheimer's and Related Dementias to study the levels of misfolded alpha-synuclein proteins in people with Alzheimer's disease.

• Curi Bio Awarded Over $4.4M in NIH Grants to Advance Translational Science

  8/23/2023

  Curi Bio proudly announces two recent SBIR grants worth $4.4 million from the National Institutes of Health to support its pioneering work on implementing human models to advance discovery of the next generation of medicines.

• FesariusTherapeutics receives prestigious NIH SBIR research grant for DermiSphere™ hydrogel technology to treat full thickness skin loss

  8/8/2023

  FesariusTherapeutics, Inc. announced they have been awarded $1.83 Million from the National Institutes of Health to further fund development of their Advanced Dermal Regeneration Scaffold for Reconstructive Surgery.

• The Access to Advanced Health Institute Receives $18 Million Award to Develop a Temperature Stable, Single-Dose Chikungunya RNA Vaccine Through a Phase 1 Clinical Trial

  8/3/2023

  The Access to Advanced Health Institute announced that it has received an $18 million award from the National Institutes of Health to develop a temperature stable, single-dose vaccine candidate for the chikungunya virus.

• Children’s Hospital Los Angeles Researcher to Lead First-Ever International Liquid Biopsy Retinoblastoma Study

  8/1/2023

  Recently, a researcher at Children’s Hospital Los Angeles developed a new way to diagnose retinoblastoma by sampling the fluid at the front of the eye.

• Caeregen Therapeutics Receives $1.4 Million Phase 2 SBIR Grant from NIH/NEI to Advance Development of Regenerative Medicine Clinical Candidate CTR-107 (Noregen™) for Retinal Diseases

  7/17/2023

  Caeregen Therapeutics announced today that it has been awarded a $1.4 million Phase 2 Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) and National Eye Institute (NEI) to advance the development of CTR-107 (Noregen™), a novel regenerative therapeutic for the treatment of retinal-related vision loss due to a wide range of inherited and age-related diseases.

• Current Surgical Receives $400k Grant from NIH's National Cancer Institute to Develop Surgery Platform for Early-Stage Cancer

  7/12/2023

  Current Surgical Inc. today announced that it has received a $400,000 grant from the National Institutes of Health (NIH) to support the development of its technology.

• CHA Hollywood Presbyterian to Participate in $40 Million Study of Alzheimer's Disease in Persons of Korean, Vietnamese, and Chinese Ancestry

  7/11/2023

  CHA Hollywood Presbyterian Medical Center is proud to announce its participation in a prestigious $40.5 million, multisite study funded by a grant from the National Institute on Aging, part of the National Institutes of Health, for the development of the Asian Cohort for Alzheimer’s Disease.

• VillageMD Selected for New NIH-Funded Study to Identify Undiagnosed Alzheimer’s Disease and Related Dementias

  6/6/2023

  VillageMD Research Institute is one of three site collaborators selected to participate in a two-year study led by Together Senior Health and University of California San Francisco.